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Elevation of [Ca2]1 of renal proximal tubular cells and downregula-
tion of mRNA of PTH-PTHrP, Via and AT! receptors in kidney of
diabetic rats. An elevation in intracellular calcium (jCa2]) in rats with
chronic renal failure and elevated blood levels of PTH is associated with
down-regulation of the mRNA of many protcins. Similarly, in phosphate
depleted animals that have normal renal function and low blood levels of
PTH, [Ca2' ] is elevated and the mRNA of PTH-PTHrP receptor is
down-regulated. The effect of elevation in [Ca24]1 on molecular machinery
of many proteins may represent a generalized phenomenon. Diabetes
mellitus may also be associated with a rise in [Ca2'] and therefore
down-regulation of the mRNA of proteins may also occur. The present
study examined the effect of streptozotoein-induced diabetes mellitus in
rats on the [Ca24]1 of the renal proximal tubular cells and on their mRNAs
of the PTH-PTHrP, Via and AT! receptors. The basal levels of [Ca2 ], of
these cells increased significantly (P < 0.01) after one day of diabetes and
remained elevated thereafter. There was a significant (r = 0.67, P < 0.01)
direct correlation between the [Ca24] of the cells and blood levels of
glucose up to 350 mgldl, and the value of [Ca2 '] plateaued with higher
concentrations of glucose. Three days of amlodipine therapy prevented
and reversed the elevated levels of [Ca2 '] despite marked hyperglycemia.
The mRNA of all three receptors in the kidney were down-regulated and
this defect was prevented by amlodipine which normalized the [Ca24]1 of
the cells. The results show that: (I) the hyperglycemia of IDDM in rats
causes a significant elevation in the basal levels of [Ca24]1 of the renal
proximal tubular cells and down-regulation of their mRNA of PTH-
PTHrP, Via and AT1 receptors; (2) normalization of the [Ca2']1 of these
cells by treatment of the diabetic rats with amlodipine prevented the
elevation of [Ca24]1 and the down-regulation of the mRNA of these
receptors; (3) these effects occurred in the presence of normal renal
function and normal blood of PTH and phosphorus.
Chronic renal failure (CRF) is associated with an elevation in
the basal levels of cytosolic calcium of many cells, and this is
mediated by the elevated blood levels of parathyroid hormone
(PTH) [11. This elevation in [Ca2]1 is associated with down-
regulation of the mRNA of many proteins including those of the
PTH-PTHrP receptor in kidney [21, liver [31, and heart [4], of
vasopressin and angiotensin II in liver [3] and of hepatic lipase [5].
Normalization of the [Ca24] by either parathyroidectomy of the
CRF rats or by their treatment with a calcium channel blocker
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prevented the down-regulation of the mRNA of these proteins
[2—5]. To provide further support for an effect of the elevation of
[Ca2]1 in the mRNA of these receptors, one needs to show such
an effect in another setting without renal failure and without
elevation in blood levels of PTH.
Diabetes mellitus is another clinical state associated with an
elevation in [Ca2]1 in many cells [6—13]. If an elevation in basal
levels of [Ca2]1 induces down-regulation of rnRNA of proteins,
one should be able to demonstrate such an effect in diabetic
animals in the absence of renal failure and elevated blood levels of
PTH.
The present study examined the effect of streptozotocin-in-
duced diabetes mellitus on [Ca24]1 of renal proximal tubular cells
of rats and on the expression of the mRNA of the receptors for
PTH-PTHrP, vasopressin and angiotensin II in the kidney, and
evaluated the effect of the treatment of these animals with the
calcium channel blocker amlodipine on these parameters.
Methods
A total of 112 Sprague-Dawley rats weighing 280 to 450 (346
4.0) g were studied. Diabetes was produced by intraperitoneal
injection (50 mg/kg body wt) of freshly prepared streptozotocin
dissolved in citrate-phosphate buffer, pH 4.4. This dose was
chosen since previous studies in our laboratory showed that it
consistently produced significant elevation in blood levels of
glucose [14].
We first examined the [Ca2]1 of renal proximal tubular cells
after 1, 2, 3 and 12 days of the injection of streptozotocin. To
examine whether treatment of the diabetic rats with amlodipine
prevents the hyperglycemia-induced elevation in [Ca2]1 in these
cells, we studied the effect of treatment of these animals with
amlodipine given for 1, 2, 3 and 12 days beginning with the
injection of streptozotocin. Amlodipine (0.1 gIg body wt) was
injected subcutaneously twice daily. In another set of experiments,
amlodipine therapy was began after 3 or 12 days of the strepto-
zotocin injection to determine whether the calcium channel
blocker can reverse the already established effect of diabetes on
[Ca2] of renal proximal tubular cells. In these experiments, the
3 or 12 days diabetic rats were divided into two groups with one of
them treated with 0.2 j.tglg body wt/day for three days, while the
other group did not receive amlodipine but was followed for an
additional three days as well. We also examined the effect of daily
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subcutaneous injection of normal rats with 0.20 jg of amlodip-
inelg bodywt/day for 12 days on [Ca2]1 of renal proximal tubular
cells.
Renal proximal tubular cells were isolated using a modification
of the method of Vinay, Gougoux and Lemieux [15] and reported
previously from our laboratory [161. Documentation of the purity
of the renal proximal tubular cells was made by electron micros-
copy. Indeed, 95% of the cells had ultrastructural characteristics
of proximal tubules.
Cytosolic calcium was estimated with Fura 2-AM. Fluorescence
was measured with a Perkin-Elmer fluorometer model LS 5B
(Perkin-Elmer, Norwalk, CT, USA) at excitation wavelengths of
340 and 380 nm and emission wavelength of 510 nm. Calculation
of [Ca2] was made using the Grynkiewicz equation [17]. We
assumed that the dissociation constant (Kd) for Ca2-Fura 2 was
225 flM. The details of this method were previously reported from
our laboratory [16].
The studies of the mRNA of hormones receptors were per-
formed in normal rats and in animals with 12 days of diabetes with
and without treatment with amlodipine. In these studies, one
kidney was used for the measurement of [Ca2] and the other
kidney was removed and immediately placed in liquid nitrogen
and kept at —70°C for the preparation of RNA. Total RNA was
isolated from the kidney by acid guanidinium-phenol-chloroform
extraction described by Chomczynski and Sacchi [18] and later
modified by them [19] using Trizol reagent. The yields of total
RNA (mg/g tissue) from the kidneys of normal rats (1.5 0.01)
was not different from that obtained from the kidneys of 12 days
diabetic animals without (1.17 0.05) or with (1.15 0.07)
treatment with amlodipine. The poly ARNA was prepared from
total RNA according to the method of Ansubel et a! [201 as
previously described [3].
R15B plasmid encoding the full length rat PTH-PTHrP recep-
tor was kindly supplied by Dr. Segre (Massachusetts General
Hospital, Boston, MA, USA). Plasmid DNA was cloned in and
recovered from competent MC 1061/P3 cells (Invitrogen Corp.,
San Diego, CA, USA), was digested with the restriction endonu-
clease HindIIl, and 1200-bp fragment of the eDNA PTH-PTHrP
receptor was recovered by gel electrophoresis as described previ-
ously [2].
pCDM8 plasmid encoding rat angiotensin Ii (AT1) receptor
(pCai8b) as described by Murphy et al [13] was kindly supplied by
Dr. Kenneth E. Bernstein (Emory University, School of Medicine,
Atlanta, GA, USA). The plasmid was cloned into competent
MCIO6I/P3 cells in LB medium containing tetracycline and
ampicillin. The isolated plasmid DNA was digested with the
restriction endonuclease Hinde III, and the 2200 hp fragment of
the eDNA of ATI receptor was recovered by gel electrophoresis.
SP657PcD plasmid encoding the rat vasopressin (Via) receptor
eDNA (15a-36) as described by Mosel et al [22] was kindly
supplied by Dr. Stephen J. Lolait (National institute of Health,
Bethesda, MD, USA). The plasmid was cloned into E. coli DH5a
(Life Technologies, Gaithersburg, MD, USA) in LB medium
containing ampicillin. Plasmid DNA was digested with the restric-
tion endonuclease Kpnl and PvuIl, and 395 bp fragment of the
eDNA of Via receptor was recovered.
An aliquot containing 30 ng of the fragment of the cDNA of the
PTH-PTHrP, ATI or Via receptors were labeled with 5 pi of 32P
dCTP (10 mCi/mI; Amersham, Arlington Height, IL, USA) using
a Random Primed DNA Labeling Kit (Boehringer-Mannheim,
Endianapolis, IN, USA) and purified through G50 Sepharose
(Sigma Chemical Co.).
Aliquots of 4 jtg of RNA for the studies of PTH-PTHrP
receptor and 4 jtg of poly A RNA for the studies of Via and AT!
were placed in separate lanes of 1.2% agarose-formaldehyde gel
and subjected to electrophoresis in IxMOPS buffer (20 mi
MOPS, 5 m sodium acetate and 10 mvt EDTA, pH 7.4) at 100
volts for three hours. The separated RNA and poly ARNAs
were transferred to Hybond N nylon paper (Amersham) with
20 X SSC (1.5 M NaCl and 0.15 M sodium citrate, pH 7.5). The
RNA and the poly A RNA were cross-linked to the membrane in
a UV Strata Linker 1800 (Stratagene, LaJolla, CA, USA).
Prehybridization of the membrane was performed in 7%
SDS,1% polyethylene glycol, 2 >< SSPE (0.9 M NaCI, 40 mM
NaOH, 50 mrvi NaH2PO4 and 5 mii EDTA, pH 7.4) for two hours
at 68°C [23]. Subsequently, the membrane was hybridized for 16
hours at 68°C with 10 ml of prehybridization solution plus the
32P-labeled eDNA probes of the PTH-PTHrP, AT1 and Via
receptors (specific activity l0' cmp/ml). The membrane was
washed twice (20 mm at 65°C) with i% SDS, 50 ifiM NaCI and 12
mM EDTA. The membrane was then autoradiographed and
analyzed by densitometric scanning (LKB Ultroscan IX, Bromma,
Sweden). Northern blot analysis from the same RNA and poly
A RNA were performed using cDNA probe of G3PDH, (Clon-
tech Lab. Inc., Palo Alto, CA).
The RNA and poly RNA of the receptors and G3PDH were
probed simultaneously and on the same membrane. The amount
of mRNA of the PTH-PTHrP, AT1 and Via receptor in the
kidney from normal animals and from diabetic rats with and
without amlodipine therapy were normalized by calculating the
ratio between the mRNA of the receptors and the G3PDH in the
same tissue.
Systolic blood pressure was measured in normal and diabetic
rats with and without amlodipine therapy before and at 3, 6, 9 and
12 days after the injection of streptozotocin using the tail-cuff
method with an electrosphygmomanometer and physiograph re-
corder MK-iIl (Narco Bio-Systems, Houston, TX, USA).
The concentrations of calcium in the serum were determined by
Perkin Elmer spectrophotometer model 505, those of phosphorus
and creatinine by an autoanalyzer (Technicon Inc., Tarrytown,
NY, USA); and of blood glucose by a Accu-Check Advantage
(Boehringer Mannheim, indianapolis, IN, USA). Serum parathy-
roid hormone (PTH) levels were estimated with radioisotopic
assay (intact PTH-Nichols Institutes Diagnostics, San Juan Cap-
istrano, CA, USA). The normal value of PTH is 10 to 65 pg/mI.
Statistical analysis for comparison between group utilized one way
analysis of variance (ANOVA) and significance was determined
with Bonnferroni - Dunn t-test, and the relationship between two
variables was determined by the correlation coefficient. Data are
reported as mean I su.
Results
The animals did not lose weight during the period of the study,
but they increased their water intake as the duration of diabetes
progressed. There were no significant differences between the
concentrations of serum creatinine, calcium, and phosphorus of
the animals with 1, 2, 3 or 12 days diabetes with and without
treatment with amlodipine; the values of these parameters were
not significantly different from those obtained in normal rats.
Plasma PTH levels after 12 days of diabetes in animals with (19±
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3 pg!ml) or without treatment with amlodipine (24 4 pg/mI)
were not different from normal (18 2.5 pg/mi). There were no
significant differences in systolic blood pressure between normal
and diabetic rats with and without treatment with amlodipine.
The blood concentrations of glucose were significantly (P <
0.01) higher than normal (88 3 mg/dl) after one day (262 38
mg/dl), two days (385 35 mg/dl), three days (419 24 mg/dI)
and 12 days (448 40 mgldl) of diabetes. The treatment with
amlodipine did not alter the blood levels of glucose significantly.
The basal levels of [Ca2]1 of the renal proximal tubular cells
were significantly (P < 0.01) higher than normal values (160 8
nM) after one day of diabetes (198 7 nsi) and remained elevated
thereafter. There was a direct and significant (r =0.67,P < 0.01)
correlation between basal levels of [Ca2I1 of these cells and blood
levels of glucose of up to 350 mg/dl, and the values of the [Ca2]1
plateaued with higher concentrations of blood glucose (Fig. 1).
Treatment of normal rats with amlodipine did not affect blood
glucose levels (83 5 vs. 86 4 mg/dl) nor the values of [Ca2J
of the renal proximal tubular cells (165 6 vs. 160 8 nM). The
effects of amlodipine treatment of diabetic rats on their blood
levels of glucose and basal levels of [Ca2 of the renal proximal
tubular cells are given in Figure 2. One or two days treatment of
diabetic rats with amlodipine did not prevent the rise in [Ca2j
of renal proximal tubular cells. However, the elevation in [Ca2]
of these cells was prevented by three days of therapy with
amlodipine (254 9 vs. 165 10 nM,P < 0.01, N = 8). This effect
of amlodipine was also observed in 12 days diabetic rats treated
with this agent (234 7vs. 175 6nM). This action of amlodipine
occurred despite hyperglycemia and when the blood levels of
glucose of the rats with and without amlodipine therapy were not
different.
Amlodipine also reversed the already established rise in [Ca2]1
of renal proximal tubular cells when given to rats after 3 or 12 days
of diabetes (Fig. 3). Indeed, three days of therapy of these rats
with amlodipine normalized the [Ca2 of the renal cells despite
significant hyperglycemia.
Figure 4 shows the autoradiographs of the mRNA of the
PTH-PTHrP, Via and AT1 receptors in kidneys from normal rats
and from 12 days of diabetic animals with and without treatment
with amlodipine, and Table 1 provides the optical densities of
mRNA expression of these receptors and of G3PDH as well as the
ratio between them. It is apparent that 12 days of diabetes was
associated with significant (P < 0.01 for PTH-PTHrP and AT1
receptors, and P < 0.05 for Via receptor) reduction in the
concentration of the mRNA of all three receptors. Normalization
of the [Ca2]1 of the renal cells by treatment of the diabetic rats
with amlodipine prevented the down-regulation of the mRNA of
all three receptors despite marked hyperglycemia.
Discussion
The results of the present study demonstrate that the induction
of diabetes meilitus in rats is associated with a significant elevation
in the basal levels of [Ca2] of their renal proximal tubular cells.
This observation is similar to other data showing that in both
experimental and human insulin-dependent diabetes mellitus
(IDDM) and non-insulin-dependent diabetes mellitus (NIDDM),
the basal levels of [Ca2] are elevated in many cells such as
adipocytes [6], hepatocytes [7], heart [8], aorta [9], platelets [101,
polymorphonuclear leukocytes [111 and B lymphocytes [13].
The elevation of the basal levels of [Ca2], in the renal proximal
tubular cells of rats with NIDDM is most likely due to the
hyperglycemia. Indeed, there was a significant correlation be-
tween the basal levels of [Ca2]1 and the blood levels of glucose of
up to 350 mg/dl. This finding is similar to those reported in
polymorphonuclear leukocytes [11] and B lymphocytes [131 of
patients with NIDDM. Thus, it is apparent that the relationships
between these two parameters are not influenced by blood levels
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of insulin since it is observed in both IDDM and NIDDM, but
rather related to the degree of the hyperglycemia.
The mechanisms responsible for the hyperglycemia induced rise
in [Ca2]1 were not investigated in the present study. However,
this could be due to both increased calcium influx into the cells
and decreased calcium exit out of them. Demerdash et al [241
have shown that hyperglycemia causes an acute increase in
calcium entry into polymorphonuclear leukocytes through the
activation of calcium channels inhibitable by various calcium
channel blockers and by stimulation of calcium release from
intracellular stores. It is possible that similar events occur in renal
proximal tubular cells. Support for this proposal is found in our
finding that the treatment of diabetic rats with amlodipine pre-
vented and reversed the rise in [Ca2]1 of these cells. Other data
exist indicating that the activity of Ca2ATPase [25, 261 and
Na-Ca2 exchanger [27] are impaired in diabetes mellitus, and
Table 1. Effects of 12 day diabetes with and without amlodipine
therapy on mRNA of PTH-PTHrP, vasopressin and angiotensin H
receptors of the kidney
Normal Diabetic
Diabetic with
amlodipine
Blood glucose mg/dl
[Ca2l1 nM
88 3.0
165 9.0
448 40.0
232 7.0
437 32.0
175 6.0
mRNA (optical density)
1) PTH-PTHrP receptor 2.35 0.05 1.31 O.007a 2.32 0.03
G3PDH 3.87 0.02 3.82 0.01 3.86 0.01
Ratio 0.61 0.01 0.34 0.004a 0.60 0.004
2) Via 1.99, 2.16 1.32 0.02 2.11 0.01
G3PDH 3.68, 3.93 3.58 0.01 3.67 0.04
Ratio 0.54, 0.55 0.37 0005b 0.57 0.003
3) AT1 3.07 0.20 2.18 0.06a 2.85 0.02
G3PDH 2.41 0.17 2.34 0.02 2.30 0.01
Ratio 1.27 0.04 0.93 0.03a 1.23 0.004
a P < 0.01 vs. normal rats and diabetic animals with amlodipine
bP < 0.05 vs. diabetic rats with amlodipine
such defects would cause a decrease in the exit of calcium out of
the cells and contribute to the rise in their basal levels of [Ca2]1.
It is of interest that the basal levels of [Ca2] of cells including
the renal proximal tubular cells plateaued and did not increase
further with blood glucose levels greater than 350 mgldl. This
finding is consistent with the notion that a steady state of elevated
basal levels of [Ca2]1 is attained with higher glycemia. This is
extremely important since continued elevation in [Ca2]1 of cells
may result in cell death.
The mRNAs of the PTH-PTHrP receptor in the kidney of rats
with chronic renal failure and elevated blood levels of PTH [2, 28]
and in those with phosphate depletion with normal renal function
and low blood levels of PTH [29] are down-regulated. In both of
these experimental settings the basal levels of [Ca2] of cells
includes the renal proximal tubular cells are elevated, suggesting
that this rise in [Ca2] plays an important role in the down-
regulation of the mRNA of this receptor. Support for this notion
is provided by the observation that the normalization of the
[Ca2]1 of the renal proximal tubular cells by the treatment of the
chronic renal failure rats or phosphate depleted animals with the
calcium calcium channel blocker (verapamil) prevented the down-
regulation of the renal mRNA of the PTH-PTHrP receptor
despite no change in chronic renal failure, blood levels of PTH or
blood levels of phosphorus [2, 29]. Similar observations were
obtained in the liver and heart of chronic renal failure in which the
basal levels of [Ca2] of hepatocytes or cardiac myocytes are
elevated [1, 4]. Indeed, the mRNAs of the PTH-PTHrP receptor
in the liver and heart [3, 4], of Via and AT1 of liver [3] and of
hepatic lipase [5] are downregulated in chronic renal failure.
Again, the normalization of the [Ca2]1 of these cells by the
treatment of the chronic renal failure animals with verapamil
prevented the down-regulation of the mRNAs of these proteins
[3—5].
The result of the present study demonstrate that an elevation in
the basal levels of [Ca2] in the renal proximal tubular cells in
another setting (diabetes mellitus) with normal renal function and
normal blood levels of PTH is also associated with down-regula-
tion of the renal mRNAs of PTH-PTHrP, Via and AT1 receptors,
and the normalization of the [Ca2]1 of these cells with amlodip-
me therapy prevented the down-regulation of the mRNAs of
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Fig. 4. Northern blot analysis of the mRNA of
the PTH-PTHrP, Via and A TI receptor and of
G3PDH of kidney from normal rats and from 12
days diabetic animals with and without
amlodipine. The exposure time of the
autoradiographs was 28 hours and the studies
for each receptor were done at the same time.
these receptors. It is theoretically possible that amlodipine, per Se,
may affect the transcription of the mRNA of these receptors.
However, this seems unlikely since the treatment of normal rats
with another calcium channel blocker (verapamil) did not affect
the amount of the mRNA of these receptors [3]. Thus, the results
of the current studies and those in the literature [2—5] indicate
that an elevation of the [Ca2] in the presence or absence of
chronic renal failure, in the presence of normal, elevated or low
blood levels of PTH and in the presence or absence of phosphate
depletion affects the molecular machinery of a variety of cells and
causes down-regulation of the mRNAs of many proteins.
Other observations support the proposal that diabetes mellitus
may be associated with an adverse effect on gene(s) expression of
cells. Weiss et al [301 reported that diabetes mellitus in rats is
associated with down-regulation of the insulin-like growth factor-I
gene. These authors, however, did not measure [Ca2] of the
kidney cells but concluded that these changes are related to the
hyperglycemia. Further, Studer and Ganas [311 found that the
basal levels of [Ca2] of hepatocytes from diabetic rats are
elevated and the vasopressin, angiotensin and glucagon-induced
rise in [Ca2]1 is reduced. They did not measure the mRNA or the
proteins of these receptors, and it is possible that reduced calcium
signal induced by these hormones is due to reduction in their
receptors. Also, Mene et al [31] found that the calcium signals
induced by angiotensin II, prostaglandin F2 alpha and arginine
vasopressin in mesangial cells cultured for five days in media
containing 22 m glucose are significantly reduced. This observa-
tion is consistent with alterations in the receptors of these agonists
in the mesangial cells, Tanaka et al [32] reported that the cell
surface [3H] bunazosin binding by cardiac myocytes from rats
with streptozotocin-induced diabetes is markedly reduced. This
binding reflects the number and/or affinity of the a adrenorecep-
tors. Also the generation of 1P3 after stimulation of the cardiac
myocytes of these animals with noradrenaline was reduced.
Treatment of these animals with verapamil corrected these ab-
normalities despite persistent hyperglycemia. These data are
consistent with the notion that diabetes adversely effects the
expression of this receptor and/or cell signalling. Since, verapamil
corrected these derangement, it is reasonable to suggest that an
elevated levels of [Ca2] of cardiac myocytes is responsible for
these derangements. The down-regulation of the mRNA of these
hormones receptors may be associated with a decreased synthesis
of receptors proteins. Measurement of these protein by Western
blot analysis are necessary to answer this question.
The mechanisms through which an elevation in [Ca2] inter-
feres with the accumulation of the mRNAs of the receptors
examined in the present study are not known. The increase in
[Ca2]1 may impair the transcription or processing of the mRNA
of these receptors and/or increase turnover of their mRNA. The
data of Young and Tashjian [33] provided evidence that a rise in
[Ca2]1 adversely affected the rate of gene transcription of TRH
receptor in the GH4C1 cells. Others have found that chronic renal
failure with elevated [Ca2] is associated with increased degra-
dation of albumin mRNA in liver [34, 35]. Thus, either one or
both mechanisms may be at work to explain the reduction in the
concentration of the mRNA of PTH-PTHrP, Via and AT1
receptors in diabetes.
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